CD274 and neoplasm: Furthermore, it was shown that C57BL/6 germ-free or microbiome-depleted mice respond poorly to PD-1/PD-L1 therapy, while the anti-tumor activity of checkpoint inhibitors is potentiated when Bifidobacterium species are administered by oral gavage after tumor challenge (3).